ImmuPharma (LON:IMM) Trading Up 4.9% – Time to Buy?

Shares of ImmuPharma plc (LON:IMM – Get Free Report) rose 4.9% during trading on Saturday . The company traded as high as GBX 4.70 ($0.06) and last traded at GBX 3.67 ($0.04). Approximately 109,382,164 shares traded hands during trading, an increase of 245% from the average daily volume of 31,664,631 shares. The stock had previously closed at GBX 3.50 ($0.04).

ImmuPharma Price Performance

The firm’s fifty day simple moving average is GBX 1.40 and its 200 day simple moving average is GBX 1.65. The company has a market capitalization of £15.30 million, a price-to-earnings ratio of -367.30 and a beta of 1.53.

About ImmuPharma

(Get Free Report)

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.

Read More

• Five stocks we like better than ImmuPharma
• Are Penny Stocks a Good Fit for Your Portfolio?
• Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
• How to Use the MarketBeat Dividend Calculator
• Why Amazon’s Next Earnings Could Trigger a Stock Breakout
• What is the MACD Indicator and How to Use it in Your Trading
• With This Kind of Data, The Fed Isn’t Cutting Rates This Year